Literature DB >> 22040088

Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

David M Anderson1, Katherine M Schmalzer, Hiromi Sato, Monika Casey, Scott S Terhune, Arthur L Haas, Jimmy B Feix, Dara W Frank.   

Abstract

Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen that possesses a type III secretion system (T3SS) critical for evading innate immunity and establishing acute infections in compromised patients. Our research has focused on the structure-activity relationships of ExoU, the most toxic and destructive type III effector produced by P. aeruginosa. ExoU possesses phospholipase activity, which is detectable in vitro only when a eukaryotic cofactor is provided with membrane substrates. We report here that a subpopulation of ubiquitylated yeast SOD1 and other ubiquitylated mammalian proteins activate ExoU. Phospholipase activity was detected using purified ubiquitin of various chain lengths and linkage types; however, free monoubiquitin is sufficient in a genetically engineered dual expression system. The use of ubiquitin by a bacterial enzyme as an activator is unprecedented and represents a new aspect in the manipulation of the eukaryotic ubiquitin system to facilitate bacterial replication and dissemination.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040088      PMCID: PMC3237844          DOI: 10.1111/j.1365-2958.2011.07904.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  50 in total

1.  Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.

Authors:  K Orth; Z Xu; M B Mudgett; Z Q Bao; L E Palmer; J B Bliska; W F Mangel; B Staskawicz; J E Dixon
Journal:  Science       Date:  2000-11-24       Impact factor: 47.728

2.  Use of limited proteolysis to identify protein domains suitable for structural analysis.

Authors:  Chris M Koth; Stephen M Orlicky; Stephan M Larson; Aled M Edwards
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

3.  Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins.

Authors:  Jianjun Sun; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2003-06-13       Impact factor: 5.157

4.  Therapeutic guidelines for Pseudomonas aeruginosa infections.

Authors:  H Giamarellou
Journal:  Int J Antimicrob Agents       Date:  2000-10       Impact factor: 5.283

5.  In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.

Authors:  Rebecca M Phillips; David A Six; Edward A Dennis; Partho Ghosh
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

6.  Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY.

Authors:  Sarah L Sayner; Dara W Frank; Judy King; Hairu Chen; John VandeWaa; Troy Stevens
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

7.  Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation.

Authors:  Tomoko Kubori; Jorge E Galán
Journal:  Cell       Date:  2003-10-31       Impact factor: 41.582

8.  Conservation in the mechanism of Nedd8 activation by the human AppBp1-Uba3 heterodimer.

Authors:  Richard N Bohnsack; Arthur L Haas
Journal:  J Biol Chem       Date:  2003-05-10       Impact factor: 5.157

9.  Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.

Authors:  Dara W Frank; Amy Vallis; Jeanine P Wiener-Kronish; Arup Roy-Burman; Edward G Spack; Brian P Mullaney; Mehdi Megdoud; James D Marks; Robert Fritz; Teiji Sawa
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

10.  The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.

Authors:  Hiromi Sato; Dara W Frank; Cecilia J Hillard; Jimmy B Feix; Ravi R Pankhaniya; Kiyoshi Moriyama; Viviane Finck-Barbançon; Adam Buchaklian; Ming Lei; Roy M Long; Jeanine Wiener-Kronish; Teiji Sawa
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  51 in total

1.  Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.

Authors:  David M Anderson; Jimmy B Feix; Andrew L Monroe; Francis C Peterson; Brian F Volkman; Arthur L Haas; Dara W Frank
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

2.  Ubiquitin activates patatin-like phospholipases from multiple bacterial species.

Authors:  David M Anderson; Hiromi Sato; Aaron T Dirck; Jimmy B Feix; Dara W Frank
Journal:  J Bacteriol       Date:  2014-11-17       Impact factor: 3.490

3.  Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A2 (PLA2) Enzyme, ExoU.

Authors:  Maxx H Tessmer; David M Anderson; Adam Buchaklian; Dara W Frank; Jimmy B Feix
Journal:  J Biol Chem       Date:  2017-01-09       Impact factor: 5.157

4.  E2~Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis.

Authors:  Jonathan N Pruneda; F Donelson Smith; Angela Daurie; Danielle L Swaney; Judit Villén; John D Scott; Andrew W Stadnyk; Isolde Le Trong; Ronald E Stenkamp; Rachel E Klevit; John R Rohde; Peter S Brzovic
Journal:  EMBO J       Date:  2014-01-20       Impact factor: 11.598

5.  VipD is a Rab5-activated phospholipase A1 that protects Legionella pneumophila from endosomal fusion.

Authors:  Andrew H Gaspar; Matthias P Machner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

6.  Identification of a ubiquitin-binding interface using Rosetta and DEER.

Authors:  Maxx H Tessmer; David M Anderson; Adam M Pickrum; Molly O Riegert; Rocco Moretti; Jens Meiler; Jimmy B Feix; Dara W Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

7.  Structural basis for the recruitment and activation of the Legionella phospholipase VipD by the host GTPase Rab5.

Authors:  María Lucas; Andrew H Gaspar; Chiara Pallara; Adriana Lucely Rojas; Juan Fernández-Recio; Matthias P Machner; Aitor Hierro
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

9.  Identification and Verification of Ubiquitin-Activated Bacterial Phospholipases.

Authors:  Maxx H Tessmer; David M Anderson; Adam M Pickrum; Molly O Riegert; Dara W Frank
Journal:  J Bacteriol       Date:  2019-01-28       Impact factor: 3.490

10.  Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Gregory H Tyson; Alan R Hauser
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.